Modeling NASH and NASH-Induced Hepatocellular Carcinoma: Faster and Better
Author:
Open Access
- 1 January 2021
- journal article
- editorial
- Published by Elsevier in Cellular and Molecular Gastroenterology and Hepatology
- Vol. 12 (3) , 1149-1150
Abstract
No abstract availableKeywords
Funding Information
- Mayo Clinic
- National Institutes of Health (P30DK084567)
- National Institute of Diabetes and Digestive and Kidney Diseases
- American Association for the Study of Liver Diseases
This publication has 7 references indexed in Scilit:
- Mechanisms and disease consequences of nonalcoholic fatty liver diseaseCell, 2021
- Nonalcoholic Steatohepatitis and HCC in a Hyperphagic Mouse Accelerated by Western DietCellular and Molecular Gastroenterology and Hepatology, 2021
- Preclinical Models for Studying NASH-Driven HCC: How Useful Are They?Cell Metabolism, 2019
- A longitudinal study of whole body, tissue, and cellular physiology in a mouse model of fibrosing NASH with high fidelity to the human conditionAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2017
- A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancerJournal of Hepatology, 2016
- Animal Models of Nonalcoholic Steatohepatitis: Eat, Delete, and InflameDigestive Diseases and Sciences, 2015
- Fat Aussie—A New Alström Syndrome Mouse Showing a Critical Role for ALMS1 in Obesity, Diabetes, and SpermatogenesisMolecular Endocrinology, 2006